#ESCCongress – Initial invasive versus conservative management of stable ischemic heart disease patients with a history of heart failure or left ventricular dysfunction: Insights from the ISCHEMIA Trial
31 Aug, 2020 | 01:30h | UTC
Commentary on Twitter
ISCHEMIA Trial: In patients w/ischemia & CHF (LVEF 35-45%), an early invasive strategy might improve event-free survival #CircESC20 #ESCCongress #AHAJournals @RenatoDLopes1 @DCRINews @DukeHeartCenter @AHAScience https://t.co/G5FDD7ipL9 pic.twitter.com/joYIxGx544
— Circulation (@CircAHA) August 29, 2020